Targeting ferroptosis as a vulnerability in cancer

被引:1345
|
作者
Lei, Guang [1 ]
Zhuang, Li [1 ]
Gan, Boyi [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; CELL-DEATH; TUMOR-SUPPRESSOR; LIPID-PEROXIDATION; PROMOTES FERROPTOSIS; SYNTHETIC LETHALITY; TRANSPORT ACTIVITY; NUCLEAR FORM; METABOLISM; PATHWAY;
D O I
10.1038/s41568-022-00459-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is an iron-dependent form of regulated cell death that is triggered by the toxic build-up of lipid peroxides on cellular membranes. In recent years, ferroptosis has garnered enormous interest in cancer research communities, partly because it is a unique cell death modality that is mechanistically and morphologically different from other forms of cell death, such as apoptosis, and therefore holds great potential for cancer therapy. In this Review, we summarize the current understanding of ferroptosis-inducing and ferroptosis defence mechanisms, dissect the roles and mechanisms of ferroptosis in tumour suppression and tumour immunity, conceptualize the diverse vulnerabilities of cancer cells to ferroptosis, and explore therapeutic strategies for targeting ferroptosis in cancer. In recent years, research in the field of ferroptosis in cancer has risen steeply in part owing to its potential to be targeted. In this Review, Lei et al. provide an up-to-date synthesis of the roles and mechanisms of ferroptosis in tumour growth and progression, including its function in tumour immunity, highlighting it as a vulnerability that can be exploited for cancer therapy.
引用
收藏
页码:381 / 396
页数:16
相关论文
共 50 条
  • [21] Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
    Muluh, Tobias Achu
    Fu, Qianqian
    Ai, Xiaojiao
    Wang, Changfeng
    Chen, Wei
    Zheng, Xiangyi
    Wang, Wei
    Wang, Maolin
    Shu, Xing-sheng
    Ying, Ying
    ANTIOXIDANTS & REDOX SIGNALING, 2024, 41 (10-12) : 616 - 636
  • [22] Novel insights on targeting ferroptosis in cancer therapy
    Sipeng Zuo
    Jie Yu
    Hui Pan
    Linna Lu
    Biomarker Research, 8
  • [23] Targeting ferroptosis in gastric cancer: Strategies and opportunities
    Le, Jiahan
    Pan, Guangzhao
    Zhang, Che
    Chen, Yitao
    Tiwari, Amit K.
    Qin, Jiang-Jiang
    IMMUNOLOGICAL REVIEWS, 2024, 321 (01) : 228 - 245
  • [24] Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?
    Subbiah, Vivek
    Gan, Boyi
    CLINICAL CANCER RESEARCH, 2022, 28 (16) : 3408 - 3410
  • [25] Temporal dynamics of ferroptosis vulnerability in a resistant cancer cell state
    Loftus, Luke
    Pienta, Ken
    Amend, Sarah
    CANCER RESEARCH, 2024, 84 (06)
  • [26] DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
    Mao, Chao
    Liu, Xiaoguang
    Zhang, Yilei
    Lei, Guang
    Yan, Yuelong
    Lee, Hyemin
    Koppula, Pranavi
    Wu, Shiqi
    Zhuang, Li
    Fang, Bingliang
    Poyurovsky, Masha V.
    Olszewski, Kellen
    Gan, Boyi
    NATURE, 2021, 593 (7860) : 586 - +
  • [27] DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
    Chao Mao
    Xiaoguang Liu
    Yilei Zhang
    Guang Lei
    Yuelong Yan
    Hyemin Lee
    Pranavi Koppula
    Shiqi Wu
    Li Zhuang
    Bingliang Fang
    Masha V. Poyurovsky
    Kellen Olszewski
    Boyi Gan
    Nature, 2021, 593 : 586 - 590
  • [28] Targeting ferroptosis, the achilles' heel of breast cancer: A review
    Liu, Yang
    Hu, Yueting
    Jiang, Yi
    Bu, Jiawen
    Gu, Xi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] Targeting lipid metabolism to trigger ferroptosis in cancer cells
    Lee, Eun-Woo
    Lee, Ji-Yoon
    Oh, Mihee
    Jang, Seo Young
    Huh, Yong-Min
    Han, Baek-Soo
    Lee, Sang Chul
    Hwang, Geum-Sook
    CANCER SCIENCE, 2025, 116 : 63 - 63
  • [30] Taking Precautions When Targeting Ferroptosis in Cancer Patients
    Nikmah, Uly Alfi
    Hidayat, Syarif
    Situmorang, Jiro Hasegawa
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 461 - 462